Skip to main content
ARQT logo

ARQT · Arcutis Biotherapeutics, Inc. · Short Interest

Track ARQT — free
$31.87 -0.95 (-2.89%) At close · Oct 21
Market Cap
$3.99B
Shares
125.69M
Volume · Oct 21 1.69M Avg daily vol (3M) 2.4M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

ARQT Latest Reported Short Interest

FINRA reported 21,688,918 ARQT shares sold short as of the September 30, 2026 settlement date, an increase of 3,230,827 shares. Days to cover was 4.83 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

ARQT Short Interest Forecast

Equibles' model estimates 21,865,179 shares sold short for the October 15, 2026 settlement, +0.8% versus the latest reported position, with a likely range of 19,962,045 to 23,883,231 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 56% chance it falls
21,865,179 +0.8% vs reported
Likely range 19,962,045 to 23,883,231 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
88/100
Short interest 17.3% of shares — P96 Days to cover 4.8 — P69 Price vs VWAP +21.4% — P98 Short-volume trend +4.7% — P70 Short interest change +17.5% — P80 Worst FTD 0.00% of shares — P25 Price spike +10

Positioning score 78.3 + catalyst boost 10 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-22 04:01 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 21,688,918 18,458,091 +3,230,827 4.83
2026-09-15 18,458,091 16,557,048 +1,901,043 8.54
2026-08-31 16,557,048 14,717,905 +1,839,143 9.41
2026-08-14 14,717,905 12,686,384 +2,031,521 8.04
2026-07-31 12,686,384 13,561,565 -875,181 10.74
2026-07-15 13,561,565 14,019,289 -457,724 9.34
2026-06-30 14,019,289 15,820,721 -1,801,432 6.33
2026-06-15 15,820,721 16,226,183 -405,462 10.04
2026-05-29 16,226,183 17,547,517 -1,321,334 8.44
2026-05-15 17,547,517 16,879,909 +667,608 7.30
2026-04-30 16,879,909 16,583,496 +296,413 16.62
2026-04-15 16,583,496 16,801,149 -217,653 15.62
2026-03-31 16,801,149 15,753,892 +1,047,257 11.11
2026-03-13 15,753,892 15,292,517 +461,375 12.56
2026-02-27 15,292,517 16,379,683 -1,087,166 9.73
2026-02-13 16,379,683 16,010,858 +368,825 14.06
2026-01-30 16,010,858 15,221,587 +789,271 13.88
2026-01-15 15,221,587 15,011,554 +210,033 8.41
2025-12-31 15,011,554 13,235,954 +1,775,600 7.86
2025-12-15 13,235,954 12,059,791 +1,176,163 6.78
2025-11-28 12,059,791 13,717,750 -1,657,959 4.34
2025-11-14 13,717,750 13,479,227 +238,523 5.45
2025-10-31 13,479,227 14,276,026 -796,799 4.79

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1787306 CUSIP 03969K108 13F (30d) 33 filings 33 filers Visit website Investor relations